FTC Clearance Of Hospira’s Mayne Acquisition Hinges On Generic Divestitures
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm must sell five generic injectable drugs to Barr under FTC consent order to complete $2 billion acquisition of Australian company.